Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Oramed Pharmaceuticals Inc. (ORMP)

Compare
2.1300
-0.0100
(-0.47%)
At close: April 1 at 4:00:01 PM EDT
2.1300
0.00
(0.00%)
After hours: April 1 at 4:05:07 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
8/31/2021
Total Revenue
--
--
1,340
2,703
2,703
Operating Expense
12,781
12,781
17,109
43,301
26,926
Operating Income
-12,781
-12,781
-15,769
-40,598
-24,223
Net Non Operating Interest Income Expense
4,103
4,103
4,589
3,564
341
Other Income Expense
-7,242
-7,242
16,268
-630
893
Pretax Income
-15,920
-15,920
5,088
-37,664
-22,989
Tax Provision
3,183
3,183
--
100
--
Net Income Common Stockholders
-19,060
-19,060
5,525
-36,561
-22,238
Diluted NI Available to Com Stockholders
-19,060
-19,060
5,525
-36,561
-22,238
Basic EPS
0.11
-0.48
0.14
-0.94
-0.78
Diluted EPS
0.11
-0.48
0.14
-0.94
-0.78
Basic Average Shares
40,791.7640
40,828.3800
40,315.0680
38,997.6490
28,469.0680
Diluted Average Shares
41,043.5970
40,828.3800
40,566.9010
38,997.6490
28,469.0680
Total Operating Income as Reported
-12,781
-12,781
-15,769
-40,598
-24,223
Total Expenses
12,781
12,781
17,109
43,301
26,926
Net Income from Continuing & Discontinued Operation
-19,060
-19,060
5,525
-36,561
-22,238
Normalized Income
-13,338.8200
-13,338.8200
-10,743
-36,063.3000
-23,131
Interest Income
4,998
4,998
8,169
3,573
347
Interest Expense
853
853
2,037
--
--
Net Interest Income
4,103
4,103
4,589
3,564
341
EBIT
-15,067
-15,067
7,125
-37,664
-24,223
EBITDA
-14,874
-14,874
7,321
-37,606
-24,146
Reconciled Depreciation
193
193
196
58
77
Net Income from Continuing Operation Net Minority Interest
-19,060
-19,060
5,525
-36,561
-22,238
Total Unusual Items Excluding Goodwill
-7,242
-7,242
16,268
-630
893
Total Unusual Items
-7,242
-7,242
16,268
-630
893
Normalized EBITDA
-7,632
-7,632
-8,947
-36,976
-25,039
Tax Rate for Calcs
0.0002
0.0002
--
0.0002
--
Tax Effect of Unusual Items
-1,520.8200
-1,520.8200
--
-132.3000
--
8/31/2021 - 5/1/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DRTS Alpha Tau Medical Ltd.
2.5000
-0.40%
 
GYRE Gyre Therapeutics, Inc.
6.41
-16.97%
 
BONS.TA Bonus BioGroup Ltd.
17.10
-2.84%
 
AARD Aardvark Therapeutics, Inc. Common Stock
8.29
+10.39%
 
CELU Celularity Inc.
1.7200
-0.58%
 
CBUS Cibus, Inc.
1.8300
-2.14%
 
BCLI Brainstorm Cell Therapeutics Inc.
1.1900
-5.56%
 
MDWD MediWound Ltd.
16.07
+3.54%
 
CGEN Compugen Ltd.
1.4100
-3.42%
 
EVGN Evogene Ltd.
1.2500
-1.57%